Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Emerging pharmacotherapies in Gaucher disease
AuthorsGregory M. Pastores
Affiliations1. University College Dublin
Phase II and III trials in systemic sclerosis: from recent FDA approvals to emerging applications of cellular therapies
AuthorsAlain Lescoat; Eisha Naveed; Dinesh Khanna
Affiliations1. University of Rennes CHU Rennes, Inserm, EHESP; 2. University of Michigan Scleroderma Program
Early investigational agents for the treatment of rosacea: drugs in phase II and III clinical development
AuthorsKejia Tian; Ji Li; Ben Wang
Affiliations1. Central South University; 2. Furong Laboratory
Injectable, oral, gene-based, and vaccine-driven PCSK9-targeted therapies: emerging clinical insights shaping the future of hypercholesterolemia management
AuthorsThusyanthy Parameswaran; Amanda J. Hooper; John R. Burnett
Affiliations1. Royal Perth Hospital & Fiona Stanley Hospital Network; 2. University of Western Australia
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
